Marquette, Uwm License Pharma Start-Up Product Shows Promise Treating Schizophrenia
The Milwaukee Journal Sentinel › January 17, 2009
Linked as:
Summary
Marquette University and the University of Wisconsin-Milwaukee have granted a license to a Milwaukee start-up company for a compound that has promise for treating schizophrenia and other central nervous system disorders.
Promentis Pharmaceuticals Inc. is the first pharmaceutical-based start-up to come out of Marquette.See the full content of this document
Extract
Marquette, Uwm License Pharma Start-Up Product Shows Promise Treating Schizophrenia
"It's something we want to encourage. It serves our mission -- when we have something that ser...
See the full content of this document
Sponsored links
